Ang, Celina <br/><br/>
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.  [electronic resource] 

 -  Journal of surgical oncology  Jan 2016 
 - 55-61 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9098 
<br/><br/><label>Standard No.: </label>10.1002/jso.24086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Hepatocellular--chemistry<br/>Erlotinib Hydrochloride--administration & dosage<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Liver Neoplasms--chemistry<br/>Lung Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Retrospective Studies<br/>Sorafenib<br/>Tumor Suppressor Protein p53--genetics<br/>beta Catenin--genetics